Medicare Lab Payment Suspensions: Responding to CMS's $1.6 Billion AI Fraud Crackdown
CMS used AI analytics to suspend 185 labs and revoke 157. How the 15-day rebuttal, the revocation appeal, and the fraud investigation that follows fit together, from former DOJ prosecutors.
Laboratory Fraud Defense 2026: DermTech Settlement & Executive Exposure
Laboratory Fraud Enforcement in 2026: DermTech Settlement, National Takedown Charges, and Criminal Exposure for Lab Owners and Executives.
Skin Substitute Rebate Programs: How DOJ Builds a Case and Where It Breaks Down
Distributor rebates were standard practice in wound care. Federal prosecutors now charge them as kickbacks and false claims. What DOJ has to prove, and where these cases break down.
DOJ Creates the National Fraud Enforcement Division: What It Means for Federal Procurement Fraud Defense
On April 7, 2026, Acting Attorney General Todd Blanche established the National Fraud Enforcement Division. Analysis of the new division, recent criminal procurement fraud cases, the statutes DOJ uses, and the key defenses available to individuals facing investigation or indictment.
Hospice Fraud: On the Law-Enforcement Horizon
Federal hospice fraud investigations are escalating in 2025 and 2026. Scott Armstrong and Drew Bradylyons, two former Assistant Chiefs at DOJ’s Fraud Section, explain the scrutiny, investigations, and charges that hospice executives and certifying physicians face in these cases.